The Chemours Company (CC)
NYSE - NYSE Delayed Price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
Pre-Market:
| Previous Close | 27.69 |
| Open | 27.37 |
| Bid | 20.48 x 900 |
| Ask | 29.89 x 800 |
| Day's Range | 26.71 - 27.76 |
| 52 Week Range | 15.10 - 39.05 |
| Volume | |
| Avg. Volume | 2,089,885 |
| Market Cap | 3.983B |
| Beta (5Y Monthly) | N/A |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -1.60 |
| Earnings Date | May 01, 2024 |
| Forward Dividend & Yield | 1.00 (3.74%) |
| Ex-Dividend Date | May 14, 2024 |
| 1y Target Est | 31.44 |
ZacksChemours (CC) Q1 Earnings: Taking a Look at Key Metrics Versus Estimates
The headline numbers for Chemours (CC) give insight into how the company performed in the quarter ended March 2024, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.
ZacksChemours (CC) Q1 Earnings Surpass Estimates
Chemours (CC) delivered earnings and revenue surprises of 28% and 0.76%, respectively, for the quarter ended March 2024. Do the numbers hold clues to what lies ahead for the stock?
GuruFocus.comThe Chemours Co (CC) Q1 2024 Earnings: Challenges Persist as Financials Trail Analyst Expectations
Chemours Faces Decline in Revenue and Net Income, Despite Cost Reduction Efforts
© 2024 Yahoo. All rights reserved.